Simplified Conservative Measures in Managing Morbidly Adherent Placenta in Beni-Suef University

NCT ID: NCT06465836

Last Updated: 2024-06-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

172 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-15

Study Completion Date

2025-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the efficacy of modified uterine artery ligation and myometrial compression as a conservative measure in improving the prognosis of the morbidly adherent placenta.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

According to the International Federation of Gynecology and Obstetrics (FIGO) guidelines, the principal surgical strategy to prevent excessive bleeding related to placenta accreta syndrome is to leave the placenta in situ and perform a primary peripartum hysterectomy at delivery. A hysterectomy may not be preferred by patients wishing to preserve fertility and is detrimental to multiple aspects of the pelvic floor, bowel, and physical functions.

Surgical principles in placenta accreta syndrome include avoiding disruption of the hypervascular placenta, stepwise devascularization, early and comprehensive blood product transfusion, and judicious use of interventional radiologic techniques such as vascular embolization.

Conservative management describes any approach whereby hysterectomy is avoided

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Placenta Accreta

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients will be randomized into two groups. One of two intraoperative surgical interventions that will be evolved during the study period:

Group A: In which 86 patients will have bilateral uterine artery ligations as described by the O- lreay technique in addition to standard conservative methods. The stitches were tied securely anteriorly.

Group B: which will include 86 patients we will do our simplified approach which include;

* After placental separation; try to grasp lower segment, or cervical flap.
* Close uterine cavity by continuous vicryl no 1 suture.
* Do 3 to 4 mattress sutures as the second layer of the uterus.
* Do uterine ligation with compression of the lower uterine segment (Modification of O, lreay suture).
Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
Randomization will be done by online research randomizer as follows (https://www.randomizer.org/about/ ):

2 Sets of 86 Unique Numbers Per Set Range: From 1 to 172

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

O- lreay technique group

Group A: In which 86 patients will have bilateral uterine artery ligations as described by O- lreay technique in addition to standard conservative methods. Briefly, two large vicryl stitches were passed using a large-sized needle below and lateral to the lower edge of the uterine incision angle in an anteroposterior direction and then redirected from back to the front through the avascular window in the posterior leaf of the broad ligament just lateral to the uterine border taking care to avoid injury to bowel posteriorly or bladder/ureter anteriorly. The stitches were tied securely anteriorly

Group Type OTHER

O, lreay suture

Intervention Type PROCEDURE

bilateral uterine artery ligations as described by O- lreay technique in addition to standard conservative methods. Briefly two large vicryl stitches were passed using a large sized needle below and lateral to the lower edge of the uterine incision angle in anteroposterior direction and then redirected from back to the front through avascular window in the posterior leaf of the broad ligament just lateral to the uterine border taking care to avoid injury to bowel posteriorly or bladder/ureter anteriorly. The stitches were tied securely anteriorly

Modified O- lreay technique group

Group B: which will include 86 patients we will do our simplified approach which includes;

* After placental separation; try to grasp the lower segment or cervical flap.
* Close uterine cavity by continuous vicryl no 1 suture.
* Do 3 to 4 mattress sutures as the second layer of the uterus.
* Do uterine ligation with compression of the lower uterine segment (Modification of O, lreay suture) as demonstrated below:

1. Pack Douglas- pouch with a towel.
2. Straight the used vicryl needle mostly no 1.
3. Try to compress and approximate anterior and posterior uterine walls.
4. Start from anterior to posterior 3- 4 cm medial to lateral uterine margin and then pass from posterior to anterior through avascular area in the broad ligament.

Group Type OTHER

modified O, lreay suture

Intervention Type PROCEDURE

1. Pack Douglas- pouch with a towel.
2. Straight the used vicryl needle mostly no 1.
3. Try to compress and approximate anterior and posterior uterine walls.
4. Start from anterior to posterior 3- 4 cm medial to lateral uterine margin and then pass from posterior to anterior through avascular area in the broad ligament. And we repeat the procedure on the other side. We can repeat this method of uterine ligation at another different plane if needed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

O, lreay suture

bilateral uterine artery ligations as described by O- lreay technique in addition to standard conservative methods. Briefly two large vicryl stitches were passed using a large sized needle below and lateral to the lower edge of the uterine incision angle in anteroposterior direction and then redirected from back to the front through avascular window in the posterior leaf of the broad ligament just lateral to the uterine border taking care to avoid injury to bowel posteriorly or bladder/ureter anteriorly. The stitches were tied securely anteriorly

Intervention Type PROCEDURE

modified O, lreay suture

1. Pack Douglas- pouch with a towel.
2. Straight the used vicryl needle mostly no 1.
3. Try to compress and approximate anterior and posterior uterine walls.
4. Start from anterior to posterior 3- 4 cm medial to lateral uterine margin and then pass from posterior to anterior through avascular area in the broad ligament. And we repeat the procedure on the other side. We can repeat this method of uterine ligation at another different plane if needed.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Gestational age more than 28 weeks as determined by LMP and ultrasound.
* Placenta previa as confirmed by ultrasound.
* Clinically stable with no or mild vaginal bleeding.
* No evidence of fetal compromise.
* Patient consent.

Exclusion Criteria

* Vaginal bleeding
* Medical disorders
Minimum Eligible Age

25 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nesreen Abdel Fattah Abdullah Shehata

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nesreen Abdel Fattah Abdullah Shehata

Professor

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beni-Suef University

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hamada Ali, A. professor

Role: CONTACT

0201007240754

nesreen shehata, professor

Role: CONTACT

0201024150605

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Morbidly adherent placenta

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Management of Placenta Accreta Spectrum
NCT04609527 UNKNOWN PHASE2/PHASE3